Invus Public Equities, L.P. (CIK 0001340097)

Latest company ownership

Shares held
38,918,903
Last filed at
May 14, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2012Q4 2025Q4
Shares held
9,250,005
Last filed at
Dec 12, 2024
Confidence Score
49.9
2025Q4
Confidence Score History
2018Q2 2025Q4
Shares held
6,317,565
Last filed at
Aug 9, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2023Q1 2025Q4
Role: 10% Owner
Shares held
5,588,366
Last filed at
Feb 3, 2021
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q4 2025Q4
Role: 10% Owner
Shares held
607,527
Last filed at
Jun 18, 2020
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Dec 10, 2024 Dec 12, 2024 Scholar Rock Holding Corp 10% Owner Sell 15.0 -1,600,000 -14.75% $66.6M
Nov 25, 2024 Nov 27, 2024 Scholar Rock Holding Corp 10% Owner Sell 15.0 -409,433 -3.64% $15.8M
Aug 7, 2024 Aug 9, 2024 CRESCENT BIOPHARMA, INC. 10% Owner Sell 22.5 -322,361 -4.85% $61.2K
Aug 5, 2024 Aug 7, 2024 CRESCENT BIOPHARMA, INC. 10% Owner Sell 26.3 -220,255 -3.21% $41.2K
Aug 1, 2024 Aug 5, 2024 CRESCENT BIOPHARMA, INC. 10% Owner Sell 22.5 -349,764 -4.85% $71.1K
Jul 26, 2024 Jul 30, 2024 CRESCENT BIOPHARMA, INC. 10% Owner Sell 20.0 -1,379,119 -16.06% $315.3K
Oct 12, 2023 Oct 16, 2023 Scholar Rock Holding Corp 10% Owner Buy 100.0 +2,199,931 24.28% $15.1M
Jun 5, 2023 Jun 5, 2023 LEXICON PHARMACEUTICALS, INC. Director Buy 100.0 +27,775,050 54.61% $72.2M
Apr 28, 2023 May 2, 2023 Scholar Rock Holding Corp 10% Owner Buy 65.0 +31,557 0.35% $202.8K
Feb 24, 2023 Feb 28, 2023 CRESCENT BIOPHARMA, INC. 10% Owner Buy 82.5 +100,000 1.18% $170K
Feb 21, 2023 Feb 23, 2023 CRESCENT BIOPHARMA, INC. 10% Owner Buy 90.0 +400,000 4.94% $712.3K
Feb 15, 2023 Feb 17, 2023 CRESCENT BIOPHARMA, INC. 10% Owner Buy 100.0 +1,515,266 23.05% $3M
Feb 9, 2023 Feb 13, 2023 CRESCENT BIOPHARMA, INC. 10% Owner Buy 56.3 +11,451 0.17% $37.1K
Jan 9, 2023 Jan 11, 2023 Scholar Rock Holding Corp 10% Owner Sell 51.3 -1,094 -0.01% $10.4K
Jan 5, 2023 Jan 9, 2023 Scholar Rock Holding Corp 10% Owner Buy 75.0 +48,774 0.54% $455.1K
Oct 25, 2022 Oct 27, 2022 Scholar Rock Holding Corp 10% Owner Buy 87.5 +130,265 1.47% $1M
Oct 3, 2022 Oct 7, 2022 Scholar Rock Holding Corp 10% Owner Buy 85.0 +99,971 1.14% $759.5K
Aug 5, 2022 Aug 9, 2022 LEXICON PHARMACEUTICALS, INC. Director Buy 96.3 +2,426,070 5.01% $6.1M
Aug 1, 2022 Aug 1, 2022 LEXICON PHARMACEUTICALS, INC. Director Buy 100.0 +16,173,800 50.14% $40.4M
Feb 1, 2021 Feb 3, 2021 Seer, Inc. 10% Owner Sell 15.0 -252,545 -4.32% $16.2M
Dec 16, 2020 Dec 17, 2020 LEXICON PHARMACEUTICALS, INC. Director Buy 100.0 +10,937,500 51.30% $35M
Dec 8, 2020 Dec 10, 2020 Seer, Inc. 10% Owner Buy 100.0 +790,000 15.64% $15M
Jun 16, 2020 Jun 18, 2020 Generation Bio Co. 10% Owner Buy 100.0 +800,000 39.72% $15.2M
Jun 27, 2018 Jun 29, 2018 LEXICON PHARMACEUTICALS, INC. Director Buy 95.0 +182,838 5.49% $2.3M
Jun 22, 2018 Jun 26, 2018 LEXICON PHARMACEUTICALS, INC. Director Buy 95.0 +253,725 8.24% $3.3M
Jun 19, 2018 Jun 21, 2018 LEXICON PHARMACEUTICALS, INC. Director Buy 85.0 +72,973 2.43% $970K
Jun 14, 2018 Jun 18, 2018 LEXICON PHARMACEUTICALS, INC. Director Buy 85.0 +45,784 1.55% $594.4K
Jun 8, 2018 Jun 12, 2018 LEXICON PHARMACEUTICALS, INC. Director Buy 95.0 +235,396 8.64% $3M
Jun 5, 2018 Jun 7, 2018 LEXICON PHARMACEUTICALS, INC. Director Buy 100.0 +325,639 13.57% $4.1M
May 31, 2018 Jun 4, 2018 LEXICON PHARMACEUTICALS, INC. Director Buy 100.0 +416,481 21.00% $5M
May 29, 2018 May 31, 2018 Scholar Rock Holding Corp 10% Owner Buy 100.0 +450,000 100.00% $6.3M
May 25, 2018 May 30, 2018 LEXICON PHARMACEUTICALS, INC. Director Buy 100.0 +433,378 27.96% $4.3M
Nov 15, 2017 Nov 17, 2017 LEXICON PHARMACEUTICALS, INC. Director Buy 100.0 +180,727 13.20% $1.8M
Nov 10, 2017 Nov 14, 2017 LEXICON PHARMACEUTICALS, INC. Director Buy 100.0 +575,946 72.60% $5.6M
Nov 26, 2014 Nov 26, 2014 LEXICON PHARMACEUTICALS, INC. Director Buy 100.0 +149,253,731 100.00% $150M
Oct 23, 2012 Oct 25, 2012 LEXICON PHARMACEUTICALS, INC. Director Buy 88.8 +3,000,000 1.07% $6.8M